Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Degradation of glycine is brought about by the glycine cleavage system, which is composed of four mitochondrial protein components: P protein (a pyridoxal phosphate-dependent glycine decarboxylase), H protein (a lipoic acid-containing protein), T protein . Additionally we are shipping Glycine Dehydrogenase Kits (17) and Glycine Dehydrogenase Proteins (7) and many more products for this protein.
Showing 10 out of 52 products:
Human Polyclonal GLDC Primary Antibody for EIA, WB - ABIN952523
Chang, Lin, Lin, Chuang, Ho, Hsu: Non-ketotic hyperglycinemia with a novel GLDC mutation in a Taiwanese child. in Acta paediatrica Taiwanica = Taiwan er ke yi xue hui za zhi 2008
These studies support a direct relationship between p53 (show TP53 Antibodies) mutations and GLDC expression in B cell lymphoma.
Glycine decarboxylase deficiency causes neural tube defects and features of non-ketotic hyperglycinemia in mice through limiting supply of one-carbon units from mitochondrial folate metabolism.
Results suggest that there is a direct correlation between ischemic injury and extracellular glycine concentration maintained by glycine decarboxylase and the glycine cleavage multienzyme system.
Data indicate no mutation was found in glycine cleavage system protein-H (show GCSH Antibodies) (GCSH (show GCSH Antibodies)) and suggest that mutations in both glycine decarboxylase (GLDC) and aminomethyltransferase (AMT (show AMT Antibodies)) are the main cause of glycine encephalopathy in Malaysian population.
study reports a novel mutation, c.2296G>T (p.Gly766Cys), in exon 19 of the glycine decarboxylase (GLDC) gene in a consanguineous Indian couple with a history of 4 neonatal deaths
Identification of a splice acceptor site mutation and five different non-synonymous variants in GLDC were found in patients with neural tube defects.
Study shows that glycine metabolism and the metabolic enzyme glycine decarboxylase (GLDC) drive tumor-initiating cells and tumorigenesis in non-small cell lung cancer.
Heterozygous GLDC gene mutation in transient neonatal hyperglycinemia.
Three adults with mild hyperglycinemia, infantile hypotonia, mental retardation, behavioral hyperirritability, and aggressive outbursts were screened for glycine decarboxylase mutations; two novel missense mutations were found.
The mutation in this nonketotic hyperglycinemia kindred led to missplicing and reduced GLDC (glycine decarboxylase) expression.
Single nucleotide substitution that abolishes the initiator methionine codon of the GLDC gene is associated with glycine encephalopathy
the nonketotic hyperglycinemia is due to a novel GLDC mutation.
forty different gene alterations in the GLDC gene were identified in patients with glycine encephalopathy
Degradation of glycine is brought about by the glycine cleavage system, which is composed of four mitochondrial protein components: P protein (a pyridoxal phosphate-dependent glycine decarboxylase), H protein (a lipoic acid-containing protein), T protein (a tetrahydrofolate-requiring enzyme), and L protein (a lipoamide dehydrogenase). The protein encoded by this gene is the P protein, which binds to glycine and enables the methylamine group from glycine to be transferred to the T protein. Defects in this gene are a cause of nonketotic hyperglycinemia (NKH).
, glycine cleavage system P protein
, glycine dehydrogenase [decarboxylating], mitochondrial
, glycine cleavage system protein P
, glycine decarboxylase P-protein
, glycine cleavage system protein P)
, glycine decarboxylase
, glycine dehydrogenase (decarboxylating; glycine decarboxylase, glycine cleavage system protein P)
, glycine decarboxylase, glycine cleavage system protein P)